Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy ; volume:14 ; number:1 ; year:2021 ; pages:622-627 ; extent:6
Case reports in oncology ; 14, Heft 1 (2021), 622-627 (gesamt 6)
- Creator
-
Gams, Polona
Dolenc Stražar, Zvezdana
Šoštarič, Maja
Bošnjak, Matic
Kšela, Juš
- DOI
-
10.1159/000514981
- URN
-
urn:nbn:de:101:1-2021051300573496958400
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
19.08.2025, 7:40 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gams, Polona
- Dolenc Stražar, Zvezdana
- Šoštarič, Maja
- Bošnjak, Matic
- Kšela, Juš
Other Objects (12)
Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Melanoma : Biologically Targeted Therapeutics
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Myopericytoma mimicking subcutaneous melanoma metastasis
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Platelet surface receptors and melanoma metastasis
Malignant melanoma metastasis to the colon
Targeted Therapies for Melanoma Brain Metastases
PMS2 amplification contributes brain metastasis from lung cancer
Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Melanoma : Biologically Targeted Therapeutics
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Myopericytoma mimicking subcutaneous melanoma metastasis
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Platelet surface receptors and melanoma metastasis
Malignant melanoma metastasis to the colon
Targeted Therapies for Melanoma Brain Metastases
PMS2 amplification contributes brain metastasis from lung cancer
Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Melanoma : Biologically Targeted Therapeutics
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Myopericytoma mimicking subcutaneous melanoma metastasis
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Platelet surface receptors and melanoma metastasis
Malignant melanoma metastasis to the colon
Targeted Therapies for Melanoma Brain Metastases